These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6509443)

  • 21. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
    Hsu DW; Efird JT; Hedley-Whyte ET
    J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen receptors in patients with brain tumors].
    Sun KH
    Zhonghua Wai Ke Za Zhi; 1989 May; 27(5):299-300, 318. PubMed ID: 2806009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms.
    Liu J; Chen G; Meng XY; Liu ZH; Dong S
    Pathol Res Pract; 2014 Dec; 210(12):830-5. PubMed ID: 25305147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
    Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
    Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
    Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioisotopic quantification of hormone receptors in brain tumors and their clinical implications].
    Vaquero J; Martínez R; Marcos ML; Liaño H; Bravo G
    Arch Neurobiol (Madr); 1983; 46(4):233-42. PubMed ID: 6651434
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormone receptors in initially excised versus recurrent intracranial meningiomas.
    Rubinstein AB; Loven D; Geier A; Reichenthal E; Gadoth N
    J Neurosurg; 1994 Aug; 81(2):184-7. PubMed ID: 8027799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomas.
    Jones LA; Edwards CL; Freedman RS; Tan MT; Gallager HS
    Int J Cancer; 1983 Nov; 32(5):567-71. PubMed ID: 6315602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estrogen and progesterone hormonal receptors in meningioma. Results and comments apropos of 26 cases].
    Jan M; Picaper G
    Neurochirurgie; 1984; 30(6):373-7. PubMed ID: 6527709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of the estrogen receptor and progesterone receptor in human cervical carcinoma].
    Han S; Yang Z; He B; Peng Z; Cao Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):65-7. PubMed ID: 1398629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progesterone receptors in ovarian neoplasms.
    Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins Y; Esmailian F; Leuchter RS; DeLange RJ
    Gynecol Oncol; 1983 Jun; 15(3):299-304. PubMed ID: 6862289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs.
    Sartin EA; Barnes S; Kwapien RP; Wolfe LG
    Am J Vet Res; 1992 Nov; 53(11):2196-200. PubMed ID: 1466519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva.
    Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins YL; DeLange RJ
    Gynecol Oncol; 1983 Feb; 15(1):27-31. PubMed ID: 6822366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG; Arroyo JG; Girgenti AJ
    Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA
    Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogen receptors in meningiomas and neurinomas (author's transl)].
    Fujimoto M; Yoshino E; Ueda S; Hirakawa K; Kusanishi H; Ohono Y; Tamaya T
    No To Shinkei; 1982 Apr; 34(4):399-404. PubMed ID: 7093077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.